Your browser doesn't support javascript.
loading
Effects of blood pressure-lowering drugs in heart failure: a systematic review and meta-analysis of randomized controlled trials.
Pinho-Gomes, Ana-Catarina; Azevedo, Luis; Bidel, Zeinab; Nazarzadeh, Milad; Canoy, Dexter; Copland, Emma; Salam, Abdul; Rodgers, Anthony; Kotecha, Dipak; Rahimi, Kazem.
Afiliação
  • Pinho-Gomes AC; The George Institute for Global Health.
  • Azevedo L; Deep Medicine, Oxford Martin School, University of Oxford.
  • Bidel Z; Department of Community Medicine, Information and Health Decision Sciences, Centre for Health Technology and Services Research, Faculty of Medicine, University of Porto, Porto, Portugal.
  • Nazarzadeh M; Collaboration Center of Meta-Analysis Research, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran.
  • Canoy D; The George Institute for Global Health.
  • Copland E; Deep Medicine, Oxford Martin School, University of Oxford.
  • Salam A; The George Institute for Global Health.
  • Rodgers A; Deep Medicine, Oxford Martin School, University of Oxford.
  • Kotecha D; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford.
  • Rahimi K; Deep Medicine, Oxford Martin School, University of Oxford.
J Hypertens ; 37(9): 1757-1767, 2019 09.
Article em En | MEDLINE | ID: mdl-30950980
: We aimed to combine evidence from all heart failure trials that have investigated the effects of drugs with blood pressure (BP)-lowering properties to assess the extent to which such drugs reduce BP in heart failure, the association between the net change in BP between treatment arms and cause-specific outcomes and whether treatment effects (efficacy and safety) vary according to baseline BP. We conducted a systematic review and meta-analysis including randomized clinical trials of drugs with BP-lowering properties in patients with chronic heart failure with at least 300 patient-years follow-up. We included a total of 37 trials (91 950 patients) and showed that treatment with drugs with BP-lowering properties resulted in a small but significant decrease in SBP in patients with heart failure with no evidence that the efficacy and safety of those drugs varied according to baseline BP.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pressão Sanguínea / Fármacos Cardiovasculares / Insuficiência Cardíaca Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pressão Sanguínea / Fármacos Cardiovasculares / Insuficiência Cardíaca Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article